The ETS Factor ESE3/EHF Represses IL-6 Preventing STAT3 Activation and Expansion of the Prostate Cancer Stem-Like Compartment

Oncotarget - United States
doi 10.18632/oncotarget.12525
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Role of the IL-6-JAK1-STAT3-Oct-4 Pathway in the Conversion of Non-Stem Cancer Cells Into Cancer Stem-Like Cells

Cellular Signalling
Cell Biology
2013English

Saffron Carotenoids Inhibit STAT3 Activation and Promote Apoptotic Progression in IL-6-stimulated Liver Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

Vasoactive Intestinal Peptide Represses Activation of Tumor-Associated Macrophages in Gastric Cancer via Regulation of TNFα, IL-6, IL-12 and iNOS

International Journal of Oncology
Cancer ResearchOncology
2015English

175 the Ets-Transcription Factor Etv1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer

Gastroenterology
HepatologyGastroenterology
2015English

Identification of ETS-like Transcription Factor 4 as a Novel Androgen Receptor Target in Prostate Cancer Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2008English

Expression Characteristics of Prostate-Derived Ets Factor Support a Role in Breast and Prostate Cancer Progression

Human Pathology
Forensic MedicinePathology
2007English

STAT3 Activation by KSHV Correlates With IL-10, IL-6 and IL-23 Release and an Autophagic Block in Dendritic Cells

Scientific Reports
Multidisciplinary
2014English

The ETS Family Member TEL Binds to Nuclear Receptors RAR and RXR and Represses Gene Activation

PLoS ONE
Multidisciplinary
2011English

Interaction of Ets-1 With HDAC1 Represses IL-10 Expression in Th1 Cells

Journal of Immunology
AllergyImmunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy